Cargando…
Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
Autores principales: | Pazhani, Jayanthi, Jayaraman, Selvaraj, Veeraraghavan, Vishnu Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389241/ https://www.ncbi.nlm.nih.gov/pubmed/37093067 http://dx.doi.org/10.1097/JS9.0000000000000018 |
Ejemplares similares
-
Molecular docking analysis of imiquimod with the TGF-β targets for oral carcinoma
por: Pazhani, Jayanthi, et al.
Publicado: (2023) -
Molecular docking analysis of cetuximab with NOTCH signalling pathway targets for oral cancer
por: Pazhani, Jayanthi, et al.
Publicado: (2023) -
Molecular docking analysis of proflavin with the Wnt pathway targets for OSCC
por: Pazhani, Jayanthi, et al.
Publicado: (2023) -
The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2023) -
Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3)
por: Jayaraman, Selvaraj, et al.
Publicado: (2023)